BridgeBio Pharma Inc (BBIO)

Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell

$33.24

Buy

$33.79

arrow-up$0.10 (+0.30%)

Prices updated at 17 May 2025, 00:59 EDT
| Prices minimum 15 mins delay
|
Prices in USD
NASDAQ
arrow-up0.52%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Biotechnology
Chairman
-
CEO
Dr. Neil Kumar, PhD
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
730
Head office
3160 Porter Drive
Palo Alto
United States
94304
mobile
+1 650 391-9740
letter
-
computer
Company website

Key personnel

Owner name
chevron-l-regular
chevron-r-regular
Salary
Dr. Thomas Trimarchi, PhD
Principal Financial Officer and President
0.64m
Dr. Charles J. Homcy,M.D.
Lead director
0.05m
Mr. Fred Hassan
Lead Independent Director
0.05m
Mr. James C. Momtazee
Independent Director
0.05m
Dr. Randal W. Scott,PhD
Independent Director
0.05m
Dr. Frank P. McCormick, D.Sc.,F.R.S.,PhD
Director
0.05m
Dr. Eric Aguiar, M.D.
Independent Director
0.05m
Mr. Ali J. Satvat
Independent Director
0.05m
Mr. Douglas A. Dachille
Independent Director
0.05m
Dr. Neil Kumar, PhD
Director; Chief Executive Officer of the Company and Eidos Therapeutics, Inc.
0.99m
Ms. Jennifer E. Cook
Independent Director
0.05m
Mr. Ronald J. Daniels
Independent Director
0.05m
Dr. Andrew W. Lo, PhD
Independent Director
0.05m
Dr. Hannah A. Valantine, M.D.
Independent Director
0.05m
Ms. Andrea John Ellis
Independent Director
0.05m
Ms. Maricel M. Apuli
Chief Accounting Officer
-

Top 5 shareholders

Owner name
chevron-l-regular
chevron-r-regular
No. of shares
KKR Genetic Disorder LP25,260,971
Kohlberg Kravis Roberts & Co LP25,260,971
Viking Global Investors LP25,120,991
Vanguard Group Inc14,900,145
BlackRock Inc13,357,496

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
30 Dec 2024-
30 Dec 2024-
30 Dec 2024-
30 Dec 2024-
30 Dec 2024-
30 Dec 2024-
26 Dec 2024-
24 Dec 2024-
24 Dec 2024-
10 Dec 2024-
10 Dec 2024-
10 Dec 2024-
19 Nov 2024-
19 Nov 2024-
19 Nov 2024-
16 Nov 2024-
16 Nov 2024-
16 Nov 2024-
16 Nov 2024-
16 Nov 2024-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.